Aptimmune Biologics

Aptimmune Biologics has developed advanced enabling technologies, including the Barricade® platform, to address critical swine diseases such as Porcine Reproductive and Respiratory Syndrome virus and Swine Influenza A virus across multiple geographies. Their ongoing R&D efforts focus on creating vaccines against the highly contagious African Swine Fever virus to assist regions severely impacted by the disease.